Tessari Eben bought KNSA
August 18, 2025 · Form 4 insider transaction
Tessari Eben bought 6,500 shares of Kiniksa Pharmaceuticals International, plc at $8.83 per share, a transaction worth $57.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,500
Price
$8.83
Total value
$57.4K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateAugust 18, 2025
Filing dateAugust 20, 2025
Shares owned after56,415
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.